KANCERA AB |
End-of-day quote
Other stock markets
|
||
| - SEK | - |
|
| 05-16 | Kancera AB Provides Operational Update Regarding the Kandova Study and Reports Increased Patient Recruitment | CI |
| 05-08 | Kancera AB Announces Executive Changes | CI |
Chart calendar Kancera AB
b3032a511e1.Kls8DeXTHFqS07OqhtO5CGXkBVKdTRjyM20AJZoMO_g.UGlXUqLqQx_r5oHA66rScAyvRj7pNVyFZw9Nd6hcb8pyH1JS3IZ1DuuM-g~9955bee7f3e44aac6a4fa3257a5ac352
Upcoming events on Kancera AB
Past events on Kancera AB
| 2024-05-26 | Annual General Meeting |
| 2024-05-16 | Q1 2024 Earnings Release |
| 2024-02-22 | Q4 2023 Earnings Release |
| 2023-11-16 | Q3 2023 Earnings Release |
| 2023-08-17 | Q2 2023 Earnings Release |
| 2023-05-24 | Annual General Meeting |
| 2023-05-18 | Q1 2023 Earnings Release |
| 2023-02-20 | FY 2022 Earnings Release |
| 2022-11-17 | Q3 2022 Earnings Release |
| 2022-08-22 17:00 | Interim 2022 Earnings Release |
| 2022-05-20 02:30 | Q1 2022 Earnings Release |
| 2022-02-18 02:35 | FY 2021 Earnings Release |
| 2021-11-18 | Q3 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 3,22 0,00 - | 0,00 | 0,75 0,50 50.6% | 1,04 0,60 72.5% | 0,00 |
|
EBITDA Million SEK | Released Forecast Spread | 0,00 0,00 - | 0,00 | -51,6 -53,1 2.87% | -62,0 -54,8 -13.22% | -81,3 |
|
EBIT Million SEK | Released Forecast Spread | -35,7 -38,0 6.18% | 0,00 | -51,9 -53,4 2.75% | -65,0 -58,1 -11.95% | -81,3 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 0,00 0,00 - | 0,00 | -52,5 -53,7 2.26% | -64,9 -58,4 -11.11% | -81,3 |
|
Net income Million SEK | Released Forecast Spread | 0,00 0,00 - | -45,7 | -52,5 -53,7 2.26% | -64,9 -58,4 -11.11% | -81,3 |
|
EPS SEK | Released Forecast Spread | 0,00 0,00 - | -0,82 | -0,90 -1,00 10% | -0,49 -0,70 30% | -0,70 |
| Announcement Date | 21/02/20 | 18/02/22 | 21/02/23 | 23/02/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,44 0,00 - | 0,00 0,00 - | 0,00 | 0,00 |
|
EBITDA Million SEK | Released Forecast Spread | -17,1 -10,2 -67.62% | -18,2 -13,5 -35.06% | -10,5 -17,7 40.8% | -19,0 -12,0 -58.22% | -13,4 -20,3 34.01% | -20,3 | -20,3 |
|
EBIT Million SEK | Released Forecast Spread | -17,2 -10,3 -66.86% | -18,3 -13,6 -34.73% | -10,5 -17,7 40.42% | -19,0 -12,0 -58.22% | -13,4 -20,3 34.01% | -20,3 | -20,3 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -17,5 -10,3 -69.89% | -18,2 -13,6 -33.74% | -10,7 -17,7 39.36% | -18,5 -12,0 -53.9% | -13,0 -20,3 36.15% | -20,3 | -20,3 |
|
EPS SEK | Released Forecast Spread | -0,22 -0,13 -69.23% | -0,23 -0,16 -43.75% | -0,13 -0,22 40.91% | -0,23 -0,15 -53.33% | -0,13 -0,20 35% | -0,17 | -0,17 |
| Announcement Date | 19/05/23 | 18/08/23 | 17/11/23 | 23/02/24 | 17/05/24 | - | - |
More events
Past sector events for Kancera AB
| 2024-06-05 03:51 | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 2024-05-17 07:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 2024-05-15 08:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-14 16:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 16:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- KAN Stock
- Stock
- Calendar Kancera AB
